This company listing is no longer active
Elos Medtech Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Stefano Alfonsi
Chief executive officer
SEK 500.0k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 1.3yrs |
| CEO ownership | n/a |
| Management average tenure | 2.1yrs |
| Board average tenure | 2.2yrs |
Recent management updates
Recent updates
Calculating The Fair Value Of Elos Medtech AB (publ) (STO:ELOS B)
Oct 11
Is Now The Time To Look At Buying Elos Medtech AB (publ) (STO:ELOS B)?
May 23Here's Why I Think Elos Medtech (STO:ELOS B) Is An Interesting Stock
May 10Returns On Capital Are Showing Encouraging Signs At Elos Medtech (STO:ELOS B)
Apr 17We Think Elos Medtech (STO:ELOS B) Is Taking Some Risk With Its Debt
Mar 24Should Elos Medtech AB (publ) (STO:ELOS B) Be Part Of Your Dividend Portfolio?
Mar 11The President & CEO of Elos Medtech AB (publ) (STO:ELOS B), Jan Wahlström, Just Bought 28% More Shares
Feb 28Do Fundamentals Have Any Role To Play In Driving Elos Medtech AB (publ)'s (STO:ELOS B) Stock Up Recently?
Feb 24Elos Medtech (STO:ELOS B) Has Gifted Shareholders With A Fantastic 102% Total Return On Their Investment
Feb 11When Should You Buy Elos Medtech AB (publ) (STO:ELOS B)?
Jan 31How Much Are Elos Medtech AB (publ) (STO:ELOS B) Insiders Taking Off The Table?
Jan 18
Returns On Capital At Elos Medtech (STO:ELOS B) Paint An Interesting Picture
Jan 06Could The Elos Medtech AB (publ) (STO:ELOS B) Ownership Structure Tell Us Something Useful?
Dec 26Elos Medtech (STO:ELOS B) Has A Somewhat Strained Balance Sheet
Dec 13Here's Why We Don't Think Elos Medtech's (STO:ELOS B) Statutory Earnings Reflect Its Underlying Earnings Potential
Nov 30Elos Medtech AB (publ)'s (STO:ELOS B) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Nov 17CEO
Stefano Alfonsi (59 yo)
1.3yrs
Tenure
SEK 500,000
Compensation
Mr. Stefano Alfonsi serves as Director at Elos Medtech AB (publ) since December 2021 and serves as CEO & President since September 05, 2022. He served as Chairman at Elos Medtech AB (publ) from May 03, 202...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 1.3yrs | SEK 500.00k | no data | |
| Chief Financial Officer | 4.5yrs | no data | 0.0071% SEK 405.8k | |
| Chief People Officer | 1.8yrs | no data | no data | |
| Chief Commercial & Operations Officer Dental | 1.9yrs | no data | no data | |
| Managing Director of Elos Medtech in Gorlose | 2.9yrs | no data | no data | |
| Chief Commercial & Operations Officer Orthopedics | 2.9yrs | no data | no data | |
| Managing Director of Elos Medtech Tianjin Co. Ltd. | 1.8yrs | no data | no data | |
| Managing Director of Elos Medtech in Timmersdala & Skara | 2.1yrs | no data | no data | |
| Managing Director of Elos Medtech in Memphis | 2.9yrs | no data | no data | |
| Chief Executive Officer of Elos Medtech Microplast AB | no data | no data | no data |
2.1yrs
Average Tenure
56.5yo
Average Age
Experienced Management: ELOS B's management team is considered experienced (2.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 2yrs | SEK 500.00k | no data | |
| Director | 2.3yrs | no data | no data | |
| Director | 2.3yrs | no data | no data | |
| Independent Chairman of the Board | 1.6yrs | SEK 417.00k | no data | |
| Director | 2.3yrs | no data | no data | |
| Independent Director | less than a year | no data | no data |
2.2yrs
Average Tenure
58yo
Average Age
Experienced Board: ELOS B's board of directors are not considered experienced ( 2.2 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/12/21 19:49 |
| End of Day Share Price | 2023/12/19 00:00 |
| Earnings | 2023/09/30 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Elos Medtech AB (publ) is covered by 2 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Oskar Vikström | ABG Sundal Collier Sponsored |
| Andreas Kvist | Redeye |